Cargando…

Late-Onset Bartter Syndrome Type II Due to a Novel Compound Heterozygous Mutation in KCNJ1 Gene: A Case Report and Literature Review

BACKGROUND: Bartter syndrome (BS) type II is a rare autosomal recessive renal tubular disorder caused by mutations in the KCNJ1 gene, which encodes the apical renal outer medullary potassium (ROMK) channel in the thick ascending limb (TAL) of Henle’s loop. BS type II is typically considered as a dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Mi, Peng, Hui, Bi, Xin, Wang, Yan-Qiu, Zhang, Yong-Zhe, Wu, Yan, Zhang, Bei-Ru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021870/
https://www.ncbi.nlm.nih.gov/pubmed/35463019
http://dx.doi.org/10.3389/fmed.2022.862514
_version_ 1784689938886819840
author Tian, Mi
Peng, Hui
Bi, Xin
Wang, Yan-Qiu
Zhang, Yong-Zhe
Wu, Yan
Zhang, Bei-Ru
author_facet Tian, Mi
Peng, Hui
Bi, Xin
Wang, Yan-Qiu
Zhang, Yong-Zhe
Wu, Yan
Zhang, Bei-Ru
author_sort Tian, Mi
collection PubMed
description BACKGROUND: Bartter syndrome (BS) type II is a rare autosomal recessive renal tubular disorder caused by mutations in the KCNJ1 gene, which encodes the apical renal outer medullary potassium (ROMK) channel in the thick ascending limb (TAL) of Henle’s loop. BS type II is typically considered as a disorder of infancy and seldom seen in adults. CASE PRESENTATION: A 34-year-old woman was admitted with generalized body numbness and hand convulsions, without growth retardation. Laboratory tests revealed hypokalemic metabolic alkalosis, hyperreninemic hyperaldosteronism, and nephrocalcinosis. She was misdiagnosed during the initial diagnosis process and was finally diagnosed with late-onset BS type II via genetic testing through next-generation sequencing combined with Sanger sequencing. A novel compound heterozygous p.Leu207Ile/p. Cys308Arg variant in exon 5 of the KCNJ1 gene from her parents was identified and speculated to be a potential pathogenic gene variation. CONCLUSION: We report a case of late-onset BS type II with a novel compound heterozygous mutation in KCNJ1. Both variants are novel and have never been reported. Our report will have a significant impact on the diagnosis of BS in other patients without typical clinical presentations and emphasizes the importance of genetic investigation.
format Online
Article
Text
id pubmed-9021870
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90218702022-04-22 Late-Onset Bartter Syndrome Type II Due to a Novel Compound Heterozygous Mutation in KCNJ1 Gene: A Case Report and Literature Review Tian, Mi Peng, Hui Bi, Xin Wang, Yan-Qiu Zhang, Yong-Zhe Wu, Yan Zhang, Bei-Ru Front Med (Lausanne) Medicine BACKGROUND: Bartter syndrome (BS) type II is a rare autosomal recessive renal tubular disorder caused by mutations in the KCNJ1 gene, which encodes the apical renal outer medullary potassium (ROMK) channel in the thick ascending limb (TAL) of Henle’s loop. BS type II is typically considered as a disorder of infancy and seldom seen in adults. CASE PRESENTATION: A 34-year-old woman was admitted with generalized body numbness and hand convulsions, without growth retardation. Laboratory tests revealed hypokalemic metabolic alkalosis, hyperreninemic hyperaldosteronism, and nephrocalcinosis. She was misdiagnosed during the initial diagnosis process and was finally diagnosed with late-onset BS type II via genetic testing through next-generation sequencing combined with Sanger sequencing. A novel compound heterozygous p.Leu207Ile/p. Cys308Arg variant in exon 5 of the KCNJ1 gene from her parents was identified and speculated to be a potential pathogenic gene variation. CONCLUSION: We report a case of late-onset BS type II with a novel compound heterozygous mutation in KCNJ1. Both variants are novel and have never been reported. Our report will have a significant impact on the diagnosis of BS in other patients without typical clinical presentations and emphasizes the importance of genetic investigation. Frontiers Media S.A. 2022-04-07 /pmc/articles/PMC9021870/ /pubmed/35463019 http://dx.doi.org/10.3389/fmed.2022.862514 Text en Copyright © 2022 Tian, Peng, Bi, Wang, Zhang, Wu and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Tian, Mi
Peng, Hui
Bi, Xin
Wang, Yan-Qiu
Zhang, Yong-Zhe
Wu, Yan
Zhang, Bei-Ru
Late-Onset Bartter Syndrome Type II Due to a Novel Compound Heterozygous Mutation in KCNJ1 Gene: A Case Report and Literature Review
title Late-Onset Bartter Syndrome Type II Due to a Novel Compound Heterozygous Mutation in KCNJ1 Gene: A Case Report and Literature Review
title_full Late-Onset Bartter Syndrome Type II Due to a Novel Compound Heterozygous Mutation in KCNJ1 Gene: A Case Report and Literature Review
title_fullStr Late-Onset Bartter Syndrome Type II Due to a Novel Compound Heterozygous Mutation in KCNJ1 Gene: A Case Report and Literature Review
title_full_unstemmed Late-Onset Bartter Syndrome Type II Due to a Novel Compound Heterozygous Mutation in KCNJ1 Gene: A Case Report and Literature Review
title_short Late-Onset Bartter Syndrome Type II Due to a Novel Compound Heterozygous Mutation in KCNJ1 Gene: A Case Report and Literature Review
title_sort late-onset bartter syndrome type ii due to a novel compound heterozygous mutation in kcnj1 gene: a case report and literature review
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021870/
https://www.ncbi.nlm.nih.gov/pubmed/35463019
http://dx.doi.org/10.3389/fmed.2022.862514
work_keys_str_mv AT tianmi lateonsetbarttersyndrometypeiiduetoanovelcompoundheterozygousmutationinkcnj1geneacasereportandliteraturereview
AT penghui lateonsetbarttersyndrometypeiiduetoanovelcompoundheterozygousmutationinkcnj1geneacasereportandliteraturereview
AT bixin lateonsetbarttersyndrometypeiiduetoanovelcompoundheterozygousmutationinkcnj1geneacasereportandliteraturereview
AT wangyanqiu lateonsetbarttersyndrometypeiiduetoanovelcompoundheterozygousmutationinkcnj1geneacasereportandliteraturereview
AT zhangyongzhe lateonsetbarttersyndrometypeiiduetoanovelcompoundheterozygousmutationinkcnj1geneacasereportandliteraturereview
AT wuyan lateonsetbarttersyndrometypeiiduetoanovelcompoundheterozygousmutationinkcnj1geneacasereportandliteraturereview
AT zhangbeiru lateonsetbarttersyndrometypeiiduetoanovelcompoundheterozygousmutationinkcnj1geneacasereportandliteraturereview